
DEXLEVO
Miracle H
Brand
DEXLEVO
Category
Skin Booster
Origin
Korea
Interested in ordering Miracle H? Send an enquiry and our team will follow up with availability and pricing.
Overview
Miracle H is a hybrid skinbooster from the Korean Miracle range that combines polycaprolactone (PCL) with hyaluronic acid. It aims to pair the progressive collagen-stimulating effect of PCL with the immediate hydration of HA in a single product. It is positioned for general rejuvenation and deep moisturising of facial skin.
How it works
The polycaprolactone acts as a biostimulator, prompting fibroblasts to generate new collagen for progressive firming and thickening, while the hyaluronic acid provides immediate hydration and improved elasticity. Together they deliver both an instant plumping effect and a longer-term regenerative one.
Indications
- General facial rejuvenation
- Skin dehydration and dullness
- Loss of elasticity and firmness
- Fine lines and wrinkles
- Mature or sun-damaged skin
Key features
- Combines PCL biostimulation with HA hydration
- Immediate plus progressive effect
- 2 mL vial format
- Suited to mature and sun-damaged skin
- Part of the Miracle range by DEXLEVO
Benefits
- Dual-action SKU (hydration + collagen stimulation)
- Broad applicability across face, neck and hands
- Long-lasting results support repeat business
- Differentiated from HA-only booster menus
- Complements the HA-free Miracle L in the range
Composition
Polycaprolactone (PCL, cited around 20%) combined with sodium hyaluronate (hyaluronic acid); supplied in 2 mL vials.
Usage & handling
Injected into the dermis by micro-injection or cannula on the face, neck or back of the hands, typically as a course of sessions per practitioner protocol; results reported within about a week and lasting up to around a year. Store per the manufacturer's instructions in cool, dry conditions away from direct sunlight; do not freeze.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.